These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19520981)

  • 1. Sarpogrelate versus aspirin in secondary prevention of cerebral infarction: differential efficacy in diabetes? Subgroup analysis from S-ACCESS.
    Shinohara Y; Nishimaru K;
    Stroke; 2009 Aug; 40(8):2862-5. PubMed ID: 19520981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sarpogrelate-Aspirin Comparative Clinical Study for Efficacy and Safety in Secondary Prevention of Cerebral Infarction (S-ACCESS): A randomized, double-blind, aspirin-controlled trial.
    Shinohara Y; Nishimaru K; Sawada T; Terashi A; Handa S; Hirai S; Hayashi K; Tohgi H; Fukuuchi Y; Uchiyama S; Yamaguchi T; Kobayashi S; Kondo K; Otomo E; Gotoh F;
    Stroke; 2008 Jun; 39(6):1827-33. PubMed ID: 18388340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of triflusal and aspirin for prevention of vascular events in patients after cerebral infarction: the TACIP Study: a randomized, double-blind, multicenter trial.
    Matías-Guiu J; Ferro JM; Alvarez-Sabín J; Torres F; Jiménez MD; Lago A; Melo T;
    Stroke; 2003 Apr; 34(4):840-8. PubMed ID: 12649515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial.
    Shinohara Y; Katayama Y; Uchiyama S; Yamaguchi T; Handa S; Matsuoka K; Ohashi Y; Tanahashi N; Yamamoto H; Genka C; Kitagawa Y; Kusuoka H; Nishimaru K; Tsushima M; Koretsune Y; Sawada T; Hamada C;
    Lancet Neurol; 2010 Oct; 9(10):959-68. PubMed ID: 20833591
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the effectiveness of sarpogrelate on the surrogate markers for macrovascular complications in patients with type 2 diabetes.
    Park SY; Rhee SY; Oh S; Kwon HS; Cha BY; Lee HJ; Lee HC; Kim YS
    Endocr J; 2012; 59(8):709-16. PubMed ID: 22673600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteric-coated aspirin versus other antiplatelet drugs in acute non-cardioembolic ischemic stroke: post-marketing study in Japan.
    Takahashi S; Mizuno O; Sakaguchi T; Yamada T; Inuyama L
    Adv Ther; 2014 Jan; 31(1):118-29. PubMed ID: 24385407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study design of the influence of SErotonin inhibition on patients with RENAl impairment or diabetes undergoing drug-eluting stent implantation (SERENADE) study: A multicenter, open-label, prospective, randomized study.
    Lee SA; Suh JW; Park JJ; Yoon CH; Cho YS; Youn TJ; Chae IH; Kim HS; Kim SH; Choi DJ
    Contemp Clin Trials; 2015 Jul; 43():20-4. PubMed ID: 25891091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose aspirin for primary prevention of cardiovascular events in Japanese patients 60 years or older with atherosclerotic risk factors: a randomized clinical trial.
    Ikeda Y; Shimada K; Teramoto T; Uchiyama S; Yamazaki T; Oikawa S; Sugawara M; Ando K; Murata M; Yokoyama K; Ishizuka N
    JAMA; 2014 Dec; 312(23):2510-20. PubMed ID: 25401325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of sarpogrelate, a 5-HT(2A) antagonist, on platelet aggregation in patients with ischemic stroke: clinical-pharmacological dose-response study.
    Uchiyama S; Ozaki Y; Satoh K; Kondo K; Nishimaru K
    Cerebrovasc Dis; 2007; 24(2-3):264-70. PubMed ID: 17622759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective Randomized Study of Sarpogrelate Versus Clopidogrel-based Dual Antiplatelet Therapies in Patients Undergoing Femoropopliteal Arterial Endovascular Interventions: Preliminary Results.
    Chen YX; Wang WD; Song XJ; Gu YQ; Tian HY; Hu HJ; Zhao JC; Li XQ; Liu CW
    Chin Med J (Engl); 2015 Jun; 128(12):1563-6. PubMed ID: 26063354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of warfarin versus aspirin for the prevention of recurrent stroke or death: subgroup analyses from the Warfarin-Aspirin Recurrent Stroke Study.
    Sacco RL; Prabhakaran S; Thompson JL; Murphy A; Sciacca RR; Levin B; Mohr JP;
    Cerebrovasc Dis; 2006; 22(1):4-12. PubMed ID: 16567931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
    Simes J; Becattini C; Agnelli G; Eikelboom JW; Kirby AC; Mister R; Prandoni P; Brighton TA;
    Circulation; 2014 Sep; 130(13):1062-71. PubMed ID: 25156992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical value of protoparaxotril saporlirs combined with aspirin in the secondary prevention of cerebral infarction].
    Zhou BR; Xu ZQ; Liu ZF
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2008 Sep; 28(9):797-800. PubMed ID: 19065892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparative trial of triflusal and aspirin following acute myocardial infarction.
    Cruz-Fernández JM; López-Bescós L; García-Dorado D; López García-Aranda V; Cabadés A; Martín-Jadraque L; Velasco JA; Castro-Beiras A; Torres F; Marfil F; Navarro E
    Eur Heart J; 2000 Mar; 21(6):457-65. PubMed ID: 10681486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effects of sarpogrelate hydrochloride, a 5-HT2A receptor antagonist, supplemented with pioglitazone on diabetic model mice.
    Iizuka K; Hamaue N; Machida T; Hirafuji M; Tsuji M
    Endocr Res; 2009; 34(1-2):18-30. PubMed ID: 19557588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of additional treatment of sarpogrelate to aspirin therapy on platelet aggregation and plasma plasminogen activator inhibitor activity in patients with stable effort angina.
    Kajiwara I; Soejima H; Miyamoto S; Ogawa H
    Thromb Res; 2011 Dec; 128(6):547-51. PubMed ID: 21722942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of sarpogrelate and ticlopidine in bare metal coronary stent implantation.
    Tamura A; Watanabe T; Shinozaki K; Kotoku M; Yano S; Kadota J
    Int J Cardiol; 2008 May; 126(1):79-83. PubMed ID: 17507105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aspirin versus anticoagulation in young patients with cerebral infarction secondary to primary antiphospholipid syndrome].
    Arauz A; Roa LF; Hernandez B; Merlos M; Marquez JM; Artigas C; Perez A; Cantu-Brito C; Barinagarrementeria F
    Rev Neurol; 2011 Nov; 53(10):584-90. PubMed ID: 22052173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiplatelet cilostazol is beneficial in diabetic and/or hypertensive ischemic stroke patients. Subgroup analysis of the cilostazol stroke prevention study.
    Shinohara Y; Gotoh F; Tohgi H; Hirai S; Terashi A; Fukuuchi Y; Otomo E; Itoh E; Matsuda T; Sawada T; Yamaguchi T; Nishimaru K; Ohashi Y
    Cerebrovasc Dis; 2008; 26(1):63-70. PubMed ID: 18511873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of combined aspirin and extended-release dipyridamole versus clopidogrel on functional outcome and recurrence in acute, mild ischemic stroke: PRoFESS subgroup analysis.
    Bath PM; Cotton D; Martin RH; Palesch Y; Yusuf S; Sacco R; Diener HC; Estol C; Roberts R;
    Stroke; 2010 Apr; 41(4):732-8. PubMed ID: 20181679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.